Key facts
- Notable investors include AIP Asset Management (Korea).
- Status: Acquired/Merged (Operating Subsidiary).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Nexmos
- ·The full record, as it builds
Funding rounds
No funding rounds for Nexmos are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nexmos
Developer of aptamer-based technology designed to serve the cosmetics, nutraceuticals, and healthcare industries. The company's technology is used in a variety of applications, such as developing wearable diagnostic devices using contact lenses and microneedle arrays, which helps in the early diagnosis of various diseases, enabling healthcare professionals to cure degenerative brain disease.
- Sector
- Healthcare
- HQ
- Yongin, South Korea
- Founded
- 2014
- Employees
- 6
- Website
- nexmos.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Nexmos doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nexmos shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nexmos in its N-PORT filings yet. We sweep new filings monthly.